ATI RN
Cardiovascular System Practice Exam
1. Which of the following is a rare but serious condition where the pulmonary arteries become narrowed, increasing the blood pressure in the lungs?
- A. Pulmonary hypertension
- B. Pulmonary embolism
- C. Pulmonary fibrosis
- D. Aortic stenosis
Correct answer: A
Rationale: The correct answer is A, Pulmonary hypertension. Pulmonary hypertension is a rare but serious condition characterized by high blood pressure in the arteries of the lungs, which can lead to heart failure. Pulmonary embolism (choice B) involves a blockage in one of the pulmonary arteries in the lungs. Pulmonary fibrosis (choice C) is a lung disease that causes lung tissue scarring. Aortic stenosis (choice D) is a condition where the aortic valve narrows, affecting blood flow from the heart.
2. What procedure involves inserting a flexible tube with a light and camera into the airways to examine the lungs and collect samples?
- A. Bronchoscopy
- B. Thoracentesis
- C. Lung biopsy
- D. Chest X-ray
Correct answer: A
Rationale: The correct answer is A: Bronchoscopy. Bronchoscopy is a procedure that entails inserting a flexible tube with a light and camera into the airways to examine the lungs and collect tissue or fluid samples. This procedure is commonly performed to diagnose lung conditions such as infections, tumors, or obstructions. Choice B, thoracentesis, involves inserting a needle into the pleural space to remove fluid for diagnostic or therapeutic purposes related to the lungs or pleura, not the airways. Choice C, lung biopsy, typically involves obtaining tissue samples from the lungs for further examination, not directly visualizing the airways. Choice D, chest X-ray, is a diagnostic imaging technique that uses radiation to create images of the chest area, providing a different type of information compared to bronchoscopy.
3. For what reason might the nurse be given an order to administer milrinone (Primacor)?
- A. For congestive heart failure
- B. For hypertension
- C. For cardiac arrhythmias
- D. For bradycardia
Correct answer: A
Rationale: Milrinone is commonly prescribed for congestive heart failure to help improve cardiac function and alleviate symptoms. Choices B, C, and D are incorrect as milrinone is not typically used for hypertension, cardiac arrhythmias, or bradycardia. It is specifically indicated for congestive heart failure for short-term management.
4. Which type of medication helps to lower cholesterol levels in the blood?
- A. Statins
- B. Beta-blockers
- C. ACE inhibitors
- D. Diuretics
Correct answer: A
Rationale: Statins are a type of medication specifically designed to lower cholesterol levels in the blood by inhibiting an enzyme involved in cholesterol production. Beta-blockers are mainly used to treat conditions like high blood pressure and heart problems by reducing the heart rate and workload. ACE inhibitors are used to manage conditions like high blood pressure and heart failure by relaxing blood vessels. Diuretics are medications that help the body get rid of excess salt and water by increasing urine production. Therefore, in the context of lowering cholesterol levels, statins are the most appropriate choice.
5. The client is on spironolactone (Aldactone) and has a potassium level of 5.9 mEq/L. What is the nurse’s priority action?
- A. Hold the spironolactone and notify the healthcare provider.
- B. Administer potassium supplements.
- C. Continue the spironolactone as ordered.
- D. Increase the dose of spironolactone.
Correct answer: A
Rationale: The correct answer is A: Hold the spironolactone and notify the healthcare provider. A potassium level of 5.9 mEq/L is high, indicating hyperkalemia. Spironolactone is a potassium-sparing diuretic that can further increase potassium levels. Therefore, the priority action is to hold the medication to prevent exacerbating hyperkalemia and notify the healthcare provider for further guidance. Choice B is incorrect because administering potassium supplements would worsen hyperkalemia. Choice C is incorrect because continuing spironolactone could lead to a further increase in potassium levels. Choice D is incorrect because increasing the dose of spironolactone would exacerbate the hyperkalemia.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access